Michael Seiberl
Salzburg, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Glioblastoma in the real-world setting: patterns of care and outcome in the Austrian population.
Journal: Journal of neuro-oncology
Published: July 12, 2024
Beyond T cell toxicity - Intrathecal chemokine CXCL13 indicating B cell involvement in immune-related adverse events following checkpoint inhibition: A two-case series and literature review.
Journal: European journal of neurology
Published: August 30, 2023
Serum Neurofilament Light Chain as Biomarker for Cladribine-Treated Multiple Sclerosis Patients in a Real-World Setting.
Journal: International journal of molecular sciences
Published: December 19, 2022
Humoral Response to SARS-CoV-2 Antigen in Patients Treated with Monoclonal Anti-CD20 Antibodies: It Is Not All about B Cell Recovery.
Journal: Neurology international
Published: October 20, 2022
Tick-Borne Encephalitis Virus RNA Found in Frozen Goat's Milk in a Family Outbreak.
Journal: International journal of molecular sciences
Published: August 30, 2022
Cladribine Alters Immune Cell Surface Molecules for Adhesion and Costimulation: Further Insights to the Mode of Action in Multiple Sclerosis.
Journal: Cells
Published: October 17, 2021
Tetravalent Influenza Vaccine Is Not Associated With Neuroaxonal Damage in Multiple Sclerosis Patients.
Journal: Frontiers in immunology
Published: June 01, 2021
Long-term peripheral immune cell profiling reveals further targets of oral cladribine in MS.
Journal: Annals of clinical and translational neurology
Published: June 26, 2020
Successful disease control with alemtuzumab in MOG-IgG-associated demyelinating disease with MS-phenotype.
Journal: Multiple sclerosis and related disorders
Published: March 20, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026